Medical Breakthrough: Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial
“An experimental, individualized therapeutic cancer #vaccine that uses messenger RNA (mRNA) to treat #pancreaticcancer continues to show potential in a small patient group. Follow-up results from a phase 1 clinical trial show that nearly 90% of people whose immune systems responded to the vaccine were still alive up to six years after receiving the last treatment”









